Theranostics Paves the Way for Personalised Medicine in Europe (PharmaNews.EU, 30 March 2010)

30 Mar 2010

A strategic analysis of the European market has suggested improved cooperation between drug and diagnostic companies in the use of theranostics - personalised diagnostic tests - will be an important factor in enhancing the commercialisation and overall benefit of personalised medicine.